NCT01048281|Recruiting
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · Stanford University Alternate IRB Approval Number
OTHER · NIH
OTHER · Stanford University
observational
100
1 country
1
Study Start
August 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2002
Date type not reportedThis date has not been verified as actual or estimated.
January 11, 2010
Actual (reported)January 13, 2010
Actual (reported)January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
p53 activity by routine pathologic analysis
time of collection
NER activity by routine pathologic analysis
time of collection
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Adults with gastric or esophageal cancer
Stanford University School of Medicine
Stanford, California, 94305, United States
blood, tumor
James M Ford
Stanford University
First Submitted
January 11, 2010
First Posted
January 13, 2010
Study Start
August 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2099
EstimatedRadiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
December 18, 2025
Record last verified: 2025-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: